Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study
Overview
Psychiatry
Affiliations
Objective: The objective of this study was to develop and investigate the usability of a biofeedback treatment smartphone app for adolescent migraine sufferers.
Background: Biofeedback is effective in treating pediatric migraine. However, biofeedback is not widely used due to the necessity of a trained therapist and specialized equipment. Emerging digital technology, including smartphones and wearables, enables new ways of administering biofeedback.
Methods: In a prospective open-label development and usability study, 10 adolescent migraine sufferers used a newly developed biofeedback app with wearable sensors that measured their muscle tension, finger temperature, and heart rate. Three iterative rounds of usability testing, including a 2-week home testing period, were completed. A biofeedback algorithm, combining and optimizing the 3 physiological modalities, and several algorithms for sham-treatment were created. Usability was evaluated statistically and summarized thematically.
Results: Five of ten participants completed all 3 rounds of usability testing. A total of 72 biofeedback sessions were completed. Usability scoring was consistently high, with median scores ranging from 3.5 to 4.5 on a 5-point scale. The biofeedback optimization algorithm correlated excellently to the raw physiological measurements (r = 0.85, P < .001). The intervention was safe and tolerable.
Conclusion: We developed an app for young migraine sufferers to receive therapist-independent biofeedback. The app underwent a rigorous development process as well as usability and feasibility testing. It is now ready for clinical trials.
Bakker J, Barge R, Centra J, Cobb B, Cota C, Guo C NPJ Digit Med. 2025; 8(1):51.
PMID: 39856145 PMC: 11760348. DOI: 10.1038/s41746-024-01322-2.
Tandon A, Cobb B, Centra J, Izmailova E, Manyakov N, McClenahan S J Med Internet Res. 2024; 26:e57628.
PMID: 39546781 PMC: 11607562. DOI: 10.2196/57628.
Gupta A, Rajagopal M, Laksham K Cureus. 2024; 15(11):e49597.
PMID: 38161824 PMC: 10754714. DOI: 10.7759/cureus.49597.
Shah A, Noronha N, Chin-See R, Hanna C, Kadri Z, Marwaha A BMC Complement Med Ther. 2023; 23(1):275.
PMID: 37533042 PMC: 10394941. DOI: 10.1186/s12906-023-04100-x.
The Role of the Autonomic Nervous System in Headache: Biomarkers and Treatment.
Gevirtz R Curr Pain Headache Rep. 2022; 26(10):767-774.
PMID: 36063265 PMC: 9442588. DOI: 10.1007/s11916-022-01079-x.